Prohemostatic interventions in Trauma: Resuscitation-associated coagulopathy, acute traumatic coagulopathy, hemostatic resuscitation, and other hemostatic interventions

Seminars in Thrombosis and Hemostasis

Volumn 38, Issue 3, 2012, Pages 250-258

  Howard, Benjaminm ^a   Daley, Aaront ^b   Cohen, Mitchelljay ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

acute traumatic coagulopathy; coagulopathy; hemostatic interventions; hemostatic resuscitation; trauma

Indexed keywords

ANTIFIBRINOLYTIC AGENT; FIBRINOGEN; HEMOSTATIC AGENT; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBOMODULIN;

ACIDOSIS; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; DILUTION; DISEASE ASSOCIATION; DRUG EFFICACY; HEMOSTASIS; HUMAN; HYPOTHERMIA; INFLAMMATION; INJURY; PRIORITY JOURNAL; RESUSCITATION;

ACUTE DISEASE; ADOLESCENT; ADULT; BLOOD COAGULATION DISORDERS; CARDIOPULMONARY RESUSCITATION; CHILD; CHILD, PRESCHOOL; ENDOTHELIUM, VASCULAR; HEMOSTATICS; HUMANS; INFANT; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84860155517     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0032-1306435     Document Type: Article

References (80)

1. World Health Organization. Injury Chart Book. Geneva. Available at: http://whqlibdoc.who.int/publications/924156220x.pdf. Accessed on January 15, 2012
2. An G. In silico experiments of existing and hypothetical cytokine-directed clinical trials using agent-based modeling. Crit Care Med: 2004; 32 10 2050 2060 (Pubitemid 39372539)
3. Holcomb JB, McMullin NR, Pearse L., et al. Causes of death in U.S. Special Operations Forces in the global war on terrorism: 2001-2004. Ann Surg: 2007; 245 6 986 991 (Pubitemid 46809302)
4. Hess JR, Holcomb JB, Hoyt DB. Damage control resuscitation: the need for specific blood products to treat the coagulopathy of trauma. Transfusion: 2006; 46 5 685 686
5. Brohi K, Cohen MJ, Davenport RA. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care: 2007; 13 6 680 685 10.1097/MCC.0b013e3282f1e78f (Pubitemid 350059533)
6. Cohen MJ, Call M, Nelson M., et al. Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients. Ann Surg: 2012; 255 2 379 385
7. Cohen MJ, Brohi K, Ganter MT, Manley GT, Mackersie RC, Pittet JF. Early coagulopathy after traumatic brain injury: the role of hypoperfusion and the protein C pathway. J Trauma: 2007; 63 6 1254 1261; discussion 1261-1252
8. Hess JR, Brohi K, Dutton RP., et al. The coagulopathy of trauma: a review of mechanisms. J Trauma: 2008; 65 4 748 754 10.1097/TA.0b013e3181877a9c
9. Bouillon B, Brohi K, Hess JR, Holcomb JB, Parr MJ, Hoyt DB. Educational initiative on critical bleeding in trauma: Chicago, July 11-13, 2008. J Trauma: 2010; 68 1 225 230 10.1097/TA.0b013e3181c42815
10. Duchesne JC, McSwain NE Jr, Cotton BA., et al. Damage control resuscitation: the new face of damage control. J Trauma: 2010; 69 4 976 990 10.1097/TA.0b013e3181f2abc9
11. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma: 2003; 54 6 1127 1130 10.1097/01.TA.0000069184.82147.06 (Pubitemid 36764882)
12. Holcomb JB, Wade CE, Michalek JE., et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg: 2008; 248 3 447 458
13. Borgman MA, Spinella PC, Perkins JG., et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma: 2007; 63 4 805 813 (Pubitemid 350287298)
14. Smith CE, Yamat RA. Avoiding hypothermia in the trauma patient. Curr Opin Anaesthesiol: 2000; 13 2 167 174 (Pubitemid 30261355)
15. Tsuei BJ, Kearney PA. Hypothermia in the trauma patient. Injury: 2004; 35 1 7 15 (Pubitemid 38064448)
16. Waibel BH, Schlitzkus LL, Newell MA, Durham CA, Sagraves SG, Rotondo MF. Impact of hypothermia (below 36 degrees C) in the rural trauma patient. J Am Coll Surg: 2009; 209 5 580 588 10.1016/j.jamcollsurg.2009.07.021
17. Wolberg AS, Meng ZH, Monroe DM III, Hoffman M. A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. J Trauma: 2004; 56 6 1221 1228 (Pubitemid 38901832)
18. Kermode JC, Zheng Q, Milner EP. Marked temperature dependence of the platelet calcium signal induced by human von Willebrand factor. Blood: 1999; 94 1 199 207 (Pubitemid 29300150)
19. Martini WZ. Coagulopathy by hypothermia and acidosis: mechanisms of thrombin generation and fibrinogen availability. J Trauma: 2009; 67 1 202 208, discussion 208-209 10.1097/TA.0b013e3181a602a7
20. Dirkmann D, Hanke AA, Görlinger K, Peters J. Hypothermia and acidosis synergistically impair coagulation in human whole blood. Anesth Analg: 2008; 106 6 1627 1632 10.1213/ane.0b013e31817340ad
21. Engström M, Schött U, Romner B, Reinstrup P. Acidosis impairs the coagulation: A thromboelastographic study. J Trauma: 2006; 61 3 624 628 10.1097/01.ta.0000226739.30655.75 (Pubitemid 44400945)
22. Hirshberg A, Dugas M, Banez EI, Scott BG, Wall MJ Jr, Mattox KL. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation. J Trauma: 2003; 54 3 454 463 10.1097/01.TA.0000053245.08642.1F (Pubitemid 36383741)
23. Schreiber MA. Coagulopathy in the trauma patient. Curr Opin Crit Care: 2005; 11 6 590 597 (Pubitemid 41697333)
24. Maegele M, Lefering R, Yucel N., et al. AG Polytrauma of the German Trauma Society (DGU). Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury: 2007; 38 3 298 304 10.1016/j.injury.2006.10.003 (Pubitemid 46328919)
25. Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth: 2010; 105 2 116 121 10.1093/bja/aeq161
26. Martini WZ. Fibrinogen availability and coagulation function after hemorrhage and resuscitation in pigs. Mol Med: 2011; 17 7-8 757 761 10.2119/molmed.2010.00093
27. Martini WZ, Holcomb JB. Acidosis and coagulopathy: the differential effects on fibrinogen synthesis and breakdown in pigs. Ann Surg: 2007; 246 5 831 835 10.1097/SLA.0b013e3180cc2e94 (Pubitemid 350035660)
28. MacLeod JB, Lynn M, McKenney MG, Cohn SM, Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma: 2003; 55 1 39 44 10.1097/01.TA. 0000075338.21177.EF (Pubitemid 36919234)
29. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg: 2007; 245 5 812 818 10.1097/01.sla.0000256862. 79374.31 (Pubitemid 46684113)
30. Frith D, Brohi K. The acute coagulopathy of trauma shock: clinical relevance. Surgeon: 2010; 8 3 159 163 10.1016/j.surge.2009.10.022
31. Frith D, Goslings JC, Gaarder C., et al. Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations. J Thromb Haemost: 2010; 8 9 1919 1925 10.1111/j.1538-7836.2010.03945.x
32. Chesebro BB, Rahn P, Carles M., et al. Increase in activated protein C mediates acute traumatic coagulopathy in mice. Shock: 2009; 32 6 659 665 10.1097/SHK.0b013e3181a5a632
33. Esmon CT. The protein C pathway. Chest: 2003; 124 3, Suppl 26S 32S (Pubitemid 37128433)
34. Mosnier LO, Zampolli A, Kerschen EJ., et al. Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant. Blood: 2009; 113 23 5970 5978 10.1182/blood-2008-10-183327
35. Holcomb JB, Jenkins D, Rhee P., et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma: 2007; 62 2 307 310
36. Silverboard H, Aisiku I, Martin GS, Adams M, Rozycki G, Moss M. The role of acute blood transfusion in the development of acute respiratory distress syndrome in patients with severe trauma. J Trauma: 2005; 59 3 717 723 (Pubitemid 43014941)
37. Cotton BA, Gunter OL, Isbell J., et al. Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma: 2008; 64 5 1177 1182; discussion 1182-1183, 10.1097/TA.0b013e31816c5c80
38. Alam HB, Rhee P. New developments in fluid resuscitation. Surg Clin North Am: 2007; 87 1 55 72, vi, 10.1016/j.suc.2006.09.015 (Pubitemid 44791387)
39. Rowell SE, Barbosa RR, Diggs BS., et al. Trauma Outcomes Group. Effect of high product ratio massive transfusion on mortality in blunt and penetrating trauma patients. J Trauma: 2011; 71 2, Suppl 3 S353 S357 10.1097/TA. 0b013e318227ef53
40. Brown LM, Aro SO, Cohen MJ., et al. Trauma Outcomes Group. A high fresh frozen plasma: packed red blood cell transfusion ratio decreases mortality in all massively transfused trauma patients regardless of admission international normalized ratio. J Trauma: 2011; 71 2, Suppl 3 S358 S363 10.1097/TA. 0b013e318227f152
41. Pati S, Matijevic N, Doursout MF., et al. Protective effects of fresh frozen plasma on vascular endothelial permeability, coagulation, and resuscitation after hemorrhagic shock are time dependent and diminish between days 0 and 5 after thaw. J Trauma: 2010; 69 01 S55 S63 10.1097/TA. 0b013e3181e453d4
42. Magnotti LJ, Zarzaur BL, Fischer PE., et al. Improved survival after hemostatic resuscitation: does the emperor have no clothes? J Trauma: 2011; 70 1 97 102 10.1097/TA.0b013e3182051691
43. Snyder CW, Weinberg JA, McGwin G Jr., et al. The relationship of blood product ratio to mortality: survival benefit or survival bias? J Trauma: 2009; 66 2 358 362; discussion 362-354, 10.1097/TA.0b013e318196c3ac
44. Duchesne JC, Barbeau JM, Islam TM, Wahl G, Greiffenstein P, McSwain NE Jr. Damage control resuscitation: from emergency department to the operating room. Am Surg: 2011; 77 2 201 206
45. Rahbar MH, Fox EE, Del Junco DJ., et al. The PROMMTT Investigators. Coordination and management of multicenter clinical studies in trauma: Experience from the PRospective Observational Multicenter Major Trauma Transfusion (PROMMTT) Study. Resuscitation: 2011;. 10.1016/j.resuscitation.2011. 09.019
46. Park MS, Martini WZ, Dubick MA., et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma: 2009; 67 2 266 275; discussion 275-266, 10.1097/TA.0b013e3181ae6f1c
47. Kashuk JL, Moore EE, Wohlauer M., et al. Initial experiences with point-of-care rapid thrombelastography for management of life-threatening postinjury coagulopathy. Transfusion: 2012; 52 1 23 33 10.1111/j.1537-2995.2011. 03264.x
48. Kashuk JL, Moore EE, Sawyer M., et al. Postinjury coagulopathy management: goal directed resuscitation via POC thrombelastography. Ann Surg: 2010; 251 4 604 614 10.1097/SLA.0b013e3181d3599c
49. Johansson PI, Stissing T, Bochsen L, Ostrowski SR. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med: 2009; 17 45 10.1186/1757-7241-17-45
50. Deveras RA, Kessler CM. Reversal of waxfarin-induced anticoagulation with recombinant human factor VIIA concentrate. Ant Int Med: 2002; 137 11 884 888 (Pubitemid 35416624)
51. Friederich PW, Henny CP, Messelink EJ., et al. Effect of recombinant activated Factor VII on perioperative blood in patients undergoing retropubic prostatectomy: a double-blinded, placebo-controlled randomized trial. Lancet: 2003; 361 201 205 (Pubitemid 36126219)
52. Morey AF. Factor VIIa for correction of traumatic coagulopathy. J Urol: 2005; 174 3 968 10.1097/01.ju.0000168117.11396.89 (Pubitemid 41140651)
53. Dutton RP, McCunn M, Hyder M., et al. Factor VIIa for correction of traumatic coagulopathy. J Trauma: 2004; 57 4 709 718; discussion 718-709
54. Spinella PC, Perkins JG, McLaughlin DF., et al. The effect of recombinant activated factor VII on mortality in combat-related casualties with severe trauma and massive transfusion. J Trauma: 2008; 64 2 286 293; discussion 293-284, 10.1097/TA.0b013e318162759f
55. Dutton R, Hauser C, Boffard K., et al. CONTROL Steering Committee. Scientific and logistical challenges in designing the CONTROL trial: recombinant factor VIIa in severe trauma patients with refractory bleeding. Clin Trials: 2009; 6 5 467 479 10.1177/1740774509344102
56. Boffard KD, Riou B, Warren B., et al. NovoSeven Trauma Study Group. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma: 2005; 59 1 8 15, discussion 15-18
57. Hauser CJ, Boffard K, Dutton R., et al. CONTROL Study Group. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage. J Trauma: 2010; 69 3 489 500 10.1097/TA.0b013e3181edf36e
58. O'Connell KA, Wood JJ, Wise RP., et al. Thromboembolic adverse events after use of recombinant human coagulation Factor VIIa. JAMA: 2006; 295 3 293 298 (Pubitemid 43112957)
59. Zaaroor M, Soustiel JF, Brenner B, Bar-Lavie Y, Martinowitz U, Levi L. Administration off label of recombinant factor-VIIa (rFVIIa) to patients with blunt or penetrating brain injury without coagulopathy. Acta Neurochir (Wien): 2008; 150 7 663 668 10.1007/s00701-008-1593-y
60. McMullin NR, Kauvar DS, Currier HM, Baskin TW, Pusateri AE, Holcomb JB. The clinical and laboratory response to recombinant factor VIIA in trauma and surgical patients with acquired coagulopathy. Curr Surg: 2006; 63 4 246 251 10.1016/j.cursur.2006.03.007 (Pubitemid 44028500)
61. Knudson MM, Cohen MJ, Reidy R., et al. Trauma, transfusions, and use of recombinant factor VIIa: A multicenter case registry report of 380 patients from the Western Trauma Association. J Am Coll Surg: 2011; 212 1 87 95 10.1016/j.jamcollsurg.2010.08.020
62. Hiippala ST, Myllylä GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg: 1995; 81 2 360 365
63. Thorarinsdottir HR, Sigurbjornsson FT, Hreinsson K, Onundarson PT, Gudbjartsson T, Sigurdsson GH. Effects of fibrinogen concentrate administration during severe hemorrhage. Acta Anaesthesiol Scand: 2010; 54 9 1077 1082 10.1111/j.1399-6576.2010.02289.x
64. Kozek-Langenecker S, Srensen B, Hess JR, Spahn DR. Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Crit Care: 2011; 15 5 R239 10.1186/cc10488
65. Stinger HK, Spinella PC, Perkins JG., et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma: 2008; 64 02 S79 85; discussion S85, 10.1097/TA.0b013e318160a57b
66. Meyer MA, Ostrowski SR, Windelv NA, Johansson PI. Fibrinogen concentrates for bleeding trauma patients: what is the evidence? Vox Sang: 2011; 101 3 185 190 10.1111/j.1423-0410.2011.01478.x
67. Patanwala AE, Acquisto NM, Erstad BL. Prothrombin complex concentrate for critical bleeding. Ann Pharmacother: 2011; 45 7-8 990 999 10.1345/aph.1Q096
68. Innerhofer P. Fibrinogen and prothrombin complex concentrate for the management of massive bleeding. Wien Klin Wochenschr: 2010; 122 05 S16 S17
69. Dickneite G, Dörr B, Kaspereit F, Tanaka KA. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model. J Trauma: 2010; 68 5 1151 1157 10.1097/TA.0b013e3181b06364
70. Pragst I, Kaspereit F, Dörr B, Dickneite G. Prothrombin complex concentrate (Beriplex P/N) for control of bleeding after kidney trauma in a rabbit dilutional coagulopathy model. Thromb Res: 2010; 125 3 272 277 10.1016/j.thromres.2009.10.011
71. Dickneite G, Pragst I. Prothrombin complex concentrate vs fresh frozen plasma for reversal of dilutional coagulopathy in a porcine trauma model. Br J Anaesth: 2009; 102 3 345 354 10.1093/bja/aen391
72. Dickneite G. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of coumarin anticoagulation. Thromb Res: 2007; 119 5 643 651 10.1016/j.thromres.2006.05.011 (Pubitemid 46321505)
73. Schöchl H, Nienaber U, Maegele M., et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care: 2011; 15 2 R83 10.1186/cc10078
74. CRASH-2 collaborators, Roberts I, Shakur H., et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet: 2011; 377 1096 1101, 1101 e1091-1092, 10.1016/S0140-6736(11)60278-X
75. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) study. Arch Surg: 2011; 10.1001/archsurg.2011.287
76. Roberts I, Shakur H, Ker K, Coats T.; CRASH-2 Trial collaborators. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev: 2011; CD004896 1 CD004896 10.1002/14651858.CD004896.pub3
77. Granville-Chapman J, Jacobs N, Midwinter MJ. Pre-hospital haemostatic dressings: a systematic review. Injury: 2011; 42 5 447 459 10.1016/j.injury. 2010.09.037
78. Perkins JG, Cap AP, Weiss BM, Reid TJ, Bolan CD. Massive transfusion and nonsurgical hemostatic agents. Crit Care Med: 2008; 36 7, Suppl S325 S339 10.1097/CCM.0b013e31817e2ec5
79. Bowman PD, Wang X, Meledeo MA, Dubick MA, Kheirabadi BS. Toxicity of aluminum silicates used in hemostatic dressings toward human umbilical veins endothelial cells, HeLa cells, and RAW267.4 mouse macrophages. J Trauma: 2011; 71 3 727 732 10.1097/TA.0b013e3182033579
80. Watters JM, Van PY, Hamilton GJ, Sambasivan C, Differding JA, Schreiber MA. Advanced hemostatic dressings are not superior to gauze for care under fire scenarios. J Trauma: 2011; 70 6 1413 1419 10.1097/TA.0b013e318216b796